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22q11.2 Deletion syndrome (22q11.2DS) is one of the most common
genetic causes of intellectual disability and psychopathology1 and
one of the strongest known risk factors for developing schizophrenia
in adulthood.2,3 Studies have shown that children with 22q11.2DS
have high rates of psychopathology, especially attention-deficit
hyperactivity disorder (ADHD), anxiety disorders and oppositional
defiant disorder (ODD), and a range of neurocognitive problems
(e.g. Green et al,4 Shashi et al,5 Hooper et al6). There are, however,
considerable discrepancies in the reported rates of psychiatric
disorders stemming from the difficulties associated with recruiting
large sample sizes at similar developmental stages in such a rare
syndrome. Moreover, a specific neurocognitive profile has not
been identified.7 It is also not clear whether intellectual disability
(as assessed by an IQ test) in children with 22q11.2DS influences
performance on other cognitive measures and whether the pattern
of associations between cognitive tests is similar to this of a sample
with uncompromised cognitive functions. It also remains unclear
to what extent psychopathology in children with 22q11.2DS is a
direct consequence of their deletion (Fig. 1, Model A) or whether
this relationship is better explained by the children’s intellectual
impairment (Fig. 1, Model B).8,9 That is, does the deletion
increase risk of intellectual impairment, which subsequently
predisposes to risk of psychopathology? If this were the case, it might
be argued that psychopathology in 22q11.2DS is a non-specific
consequence of generalised intellectual impairment. Or, alternatively,
does the deletion predispose independently to both cognitive
impairments and psychopathology? This would imply that
cognitive impairments index genetic risk factors for psychiatric
disorders, rather than mediate the risk of psychopathology.
The primary goals of this study were twofold. First, to explore
differences in the prevalence and nature of psychiatric and
cognitive problems in children with 22q11.2DS compared with
their siblings. As a secondary analyses, we also explored the
relations between IQ and other cognitive measures as well as
whether the pattern of associations between the cognitive measures
is similar for children with 22q11.2DS and their siblings. Second,
to examine whether any association between deletion status and
psychopathology is mediated through intellectual impairment.
To address these issues we conducted one of the largest studies
of children with 22q11.2DS and sibling controls to date and
one of the few studies to have included both detailed psychiatric
and cognitive assessments. Based on preliminary findings on other
copy number variants (CNVs),9 we hypothesised that IQ would
not mediate the relationship between the deletion and psychiatric
problems (Model A., Fig. 1).9 As an exploratory analysis, we also
examined whether any other neurocognitive deficits mediated this
relationship.
Method
Participants
As part of the Experiences of CHildren with cOpy number
variants (ECHO) study, 80 children (50% females) with
22q11.2DS aged 6.6–14.1 years (mean 10.2, s.d. = 2.1) and 39
sibling controls (56% females) aged 6.3–14.3 years (mean 10.9,
s.d. = 2.0) were recruited from 14 genetics clinics across the UK,
the British 22q11 deletion syndrome charities Max Appeal! and
The 22Crew, and our ECHO study website (http://medicine.
cardiff.ac.uk/psychological-medicine-neuroscience/areas-research/
copy-number-variant-research/research-projects/).
Table 1 provides a sociodemographic description of the
sample. Numbers of children differ for different measures as five
children with 22q11.2DS were not able to complete all the
cognitive assessments. Furthermore, due to geographical
considerations we did not conduct any neurocognitive testing in
six children (in these cases psychiatric interviews were conducted
using video-call).
Presence of the deletion was confirmed for all children with
22q11.2DS (87.5% of families were recruited from medical
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Background
Children with 22q11.2 deletion syndrome (22q11.2DS) have
been reported to have high rates of cognitive and psychiatric
problems.
Aims
To establish the nature and prevalence of psychiatric
disorder and neurocognitive impairment in children with
22q11.2DS and test whether risk of psychopathology is
mediated by the children’s intellectual impairment.
Method
Neurocognition and psychopathology were assessed
in 80 children with 22q11.2DS (mean age 10.2 years,
s.d. = 2.1) and 39 sibling controls (mean age 10.9 years,
s.d. = 2.0).
Results
More than half (54%) of children with 22q11.2DS met
diagnostic criteria for one or more DSM-IV-TR psychiatric
disorder. These children had lower IQ (mean 76.8, s.d. = 13.0)
than controls (mean 108.6, s.d. = 15.2) (P50.001) and showed
a range of neurocognitive impairments. Increased risk of
psychopathology was not mediated by intellectual
impairment.
Conclusions
22q11.2DS is not related to a specific psychiatric phenotype
in children. Moreover, the deletion has largely independent
effects on IQ and risk of psychopathology, indicating that
psychopathology in 22q11.2DS is not a non-specific
consequence of generalised cognitive impairment.
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genetics clinics and for the remaining 12.5% medical records were
made available by the families).
Informed written consent was obtained prior to recruitment
from the carers of the children and recruitment was carried out
in agreement with protocols approved by the appropriate research
National Health Service ethics and research and development
committees.
Psychopathology
Psychopathology was assessed with the Child and Adolescent
Psychiatric Assessment (CAPA)10 by means of semi-structured in-
terview with the primary caregiver. In the section of the interview
dealing with psychotic experiences, initial screening questions
probed for any evidence of perceptual disorders or
hallucinations, delusions or psychotic abnormalities of thought
processes. If these screening questions were answered
affirmatively, the interviewer continued with more detailed
questions about the nature of possible symptoms. Specifically,
questions are included regarding content and location of auditory,
olfactory and tactile hallucinations. Questions were asked about
thought insertion and broadcast, thought echo and withdrawal
and delusional thinking. Phenomena not coded as psychotic
symptoms included hypnagogic/pompic hallucinations, eidetic
imagery, elaborated fantasies, imaginary companions, illusions,
hallucinations occurring as part of a seizure or clouded sensorium,
spots/stripes before the eyes and sensory changes associated with
headaches. Psychotic experiences were also assessed by children’s
self-reports using the same instrument. All interviews were
conducted by trained psychologists, who were supervised by a
consultant child and adolescent psychiatrist. Interviews were
audiotaped for monitoring and assignment of DSM-IV-TR11
diagnoses by the child and adolescent psychiatrist. We did not
regard ADHD, ODD, pervasive developmental disorder and mood
and anxiety disorders as mutually exclusive diagnoses.
Autistic behaviour was assessed using the Social Communication
Questionnaire (SCQ),12 which was completed by the primary
caregiver. Total scores can range from 0 to 39. The cut-off of 15,
which is suggestive of autism spectrum disorder (ASD), was used
in our analyses.
With regard to psychotropic medication, one child with
22q11.2DS and one sibling were receiving oral methylphenidate
for ADHD.
Cognition
Neurocognitive assessments were conducted by trained raters.
An estimate of general intelligence (IQ) was obtained by
administering the Wechsler Abbreviated Scale of Intelligence
(WASI; four subtests).13 Processing speed was assessed with the
Reaction Time (RTI) (child mode) test; attention and vigilance
were assessed with the Match to Sample visual search (MTS)
and the Rapid Visual Information Processing (RVP) (child mode)
tests, from the CANTAB (Cambridge Neuropsychological
Automated Battery eclipse version 3 software, Cambridge, 2006);
executive function was assessed with the Spatial Working Memory
(SWM) and the Stockings of Cambridge (SOC) tests from the
CANTAB. To obtain a global assessment of executive function
we also administered the Wisconsin Card Sorting Test (WSCT).14
Data analysis
Data analysiswas conducted using Stata (version 11) forWindowsXP.
Psychopathology (Goal 1)
The prevalence of psychiatric problems in children with
22q11.2DS compared with their siblings was examined using a
w2-test. Associations between age and psychiatric diagnoses were
examined using Spearman’s rank correlations, and association
between gender and psychiatric diagnoses were examined using
w2-tests. To examine whether any of the comorbid diagnoses
occurred more frequently than others, w2-tests were used.
Nature and prevalence of cognitive impairments (Goal 1)
All neurocognitive measures were standardised to have a mean of
zero and a standard deviation of one, apart from the ‘failure to
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Model A
Model B
Mediation model
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Group status Psychiatric diagnosis
Path C
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IQ
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Fig. 1 Representation of possible relationships between
intellectual impairment and psychopathology and the 22q11.2
deletion.
According to Model A, psychopathology is a direct consequence of the deletion,
whereas according to Model B, psychopathology can be better explained by the
intellectual impairment caused by the 22q11.2 deletion. The mediation model
examines the role of group status (children with 22q11.2DS v. sibling controls)
on psychiatric diagnosis through IQ. Del, deletion.
Table 1 Sociodemographic information of sample
%
Family ethnic background
European 91.25
Mixed 6.25
Non-European 2.5
Highest maternal educational qualification
Low: O-levels or GCSEs 38.75
Middle: A-levels/highers or vocational training 40
High: university degree and/or other higher
postgraduate qualification 20
Unknown 1.25
Family income, £
419 999 16.25
20 000–39 000 27.5
40 000–59 000 18.75
560 000 25
Unknown 12.5
Niarchou et al
maintain set’ variable of the WCST (which is categorical) and IQ
score. Apart from IQ, all other cognitive variables were not
normally distributed. To compare the mean differences in cognitive
performance of the children with 22q11.2DS with their siblings,
t-tests or, in the case of non-normally distributed cognitive variables,
Mann–Whitney U-tests were conducted. Spearman’s rank
correlations were used to estimate the correlations between IQ
and age, and IQ and gender. A t-test was used to examine whether
the average verbal IQ in children with 22q11.2DS was different
from the average performance IQ.
IQ in relation to other cognitive measures
and patterns of associations (Goal 1)
Spearman’s rank correlations were used to estimate the correlations
between IQ and other neurocognitive measures. A comparison of
the magnitudes of the correlations of the neurocognitive tests for
children with 22q11.2DS v. sibling controls was conducted following
Fisher’s r-to-z transformation.15 A two-group variance-comparison
test using the sdtest command was employed to examine whether
there was greater variation in neurocognitive performance in the
children with 22q11.2DS in relation to their siblings.
Psychopathology and cognition (Goal 2)
In order to determine whether the differences in psychiatric
diagnoses between the children with 22q11.2DS and their sibling
controls could be explained by IQ, we performed the following
analyses. Independent regressions were performed in the total
sample to determine whether the independent variable (i.e. IQ
score) predicted presence of psychiatric diagnosis (0=no diagnosis,
1 = present diagnosis). From these regressions we derived odds
ratios (ORs) and 95% confidence intervals (CIs). To facilitate
interpretation of the results, IQ score was standardised to have a
mean of 0 and a standard deviation of 1 and recoded so that
higher score indicated worse performance. These analyses were
conducted only for the psychiatric diagnoses that were
significantly different between the two groups: 1. ADHD (absent
(0) v. present (1)); 2. any anxiety disorder (absent (0) v. present
(1)); 3. ODD (absent (0) v. present (1)); 4. ASD screening
(0 = SCQ score515, 1 = SCQ score515). To test the assumption
that the relationship between IQ and psychopathology was similar
in children with 22q11.2DS and siblings and that combining the
two groups for subsequent analysis was therefore appropriate,
we assessed homogeneity of ORs using the w2-test of homogeneity.
Odds ratios and 95% confidence intervals for the associations
between IQ and psychopathology after adjusting for group status
(22q11.2DS v. siblings) were estimated using the Mantel–Haenszel
method.16
Mediation analysis was also conducted to examine the extent
to which IQ score mediated the associations between group status
and psychiatric diagnosis. Figure 1 (Model B) illustrates a
representation of the model tested. The binary_mediation command
was used to estimate the indirect effect of IQ on psychopathology,
using the product of coefficients approach, which is considered
to have good power and low type I error.17 Standard errors and
biased-corrected confidence intervals were also calculated using
bootstrapping with 5000 replications. We repeated these analyses
to explore whether the other cognitive measures mediated the
relation between the deletion and psychiatric problems. To limit
the number of statistical comparisons we examined only the
primary scores of these cognitive tests (i.e. MTS total correct;
RTI 5-choice reaction time; RVP A’; SOC problems solved in
minimum moves; and SWM between errors score, number of
perseverative errors).
Results
Psychopathology (Goal 1)
More than half (54%) of the children with 22q11.2DS met
diagnostic criteria for one or more DSM-IV-TR psychiatric
disorders, compared with 10% of the siblings, P50.001 (Table 2).
Children with 22q11.2DS exhibited higher rates of ADHD, ODD
and anxiety disorders in relation to their siblings. Furthermore,
more children with 22q11.2DS (26%) met the cut-off for probable
ASD diagnosis in relation to their siblings (5%). Psychiatric
diagnoses were not related to age or gender in the children with
22q11.2DS (data not presented). High rates of comorbidity were
observed for children with 22q11.2DS (Fig. 2): 12 (37.5%)
children with ADHD also had at least one anxiety disorder; 12
48
Table 2 DSM-IV-TR derived diagnoses in children with 22q11.2DS and their siblings
Children with 22q11.2DS Siblings
Diagnosis n (%) 95% CI, % n (%) 95% CI, % P
Any diagnosis 43 (54.5) 44–64 4 (10.5) 6–19 50.001
Any anxiety disorder 21 (26.3) 18–36 2 (5.3) 2–11 0.01
Generalised anxiety disorder 5 (6.3) 2–13 0 0–4 0.12
Panic disorder without agoraphobia 1 (1.3) 0–6 0 0–4 0.48
Panic disorder with agoraphobia 2 (2.5) 0–9 0 0–4 0.33
Agoraphobia without history of panic disorder 1 (1.3)a 0–6 0 0–4 0.49
Specific phobia 12 (15.2)a 9–24 1 (2.6) 0–9 0.04
Social phobia 14 (17.5) 11–27 2 (5.3) 2–11 0.07
Obsessive–compulsive disorder 3 (3.8) 1–10 0 0–4 0.23
Separation anxiety disorder 2 (9.1) 4–16 0 0–4 0.41
Attention-deficit hyperactivity disorder 32 (40.5)a 40–60 2 (5.3) 2–11 50.001
Oppositional defiant disorder 15 (18.8) 12–28 0a 0–4 0.005
Tic disorder 6 (7.5) 4–15 1 (2.7)a 0–9 0.31
Delusional disorder 2 (2.5) 0–9 0 0–4 0.33
Selective mutism 1 (1.3) 0–6 0 0–4 0.49
Autism spectrum disorder screeningb 20 (26.0) 18–36 2 (5.3) 2–11 0.01
22q11.2DS, 22q11.2 deletion syndrome.
a. Insufficient information to confirm diagnosis for one participant.
b. Autism spectrum disorder scoring 515 on the Social Communication Questionnaire (suggestive of autism spectrum disorder diagnosis).
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(37.5%) had ODD; and 12 (41.2%) screened positive for probable
ASD. Among children with an anxiety disorder, 7 (33.3%) also
had ODD and 11 (52.4%) screened positive for probable ASD.
Among children with ODD, 6 (30%) also screened positive for
probable ASD. None of the comorbid diagnoses occurred more
frequently than others (P40.2). Overall, psychotic experiences
(parent and self-report combined) were reported by 10% of
children with 22q11.2DS, and 8% of their siblings. Parents
reported psychotic experiences for 5% of the children with
22q11.2DS and none of their siblings, whereas 6% of the children
with 22q11.2DS and 8% of their siblings self-reported psychotic
experiences. Parental and child reports were in agreement for only
one child (who had 22q11.2DS).
Nature and prevalence of cognitive impairments
(Goal 1)
Children with 22q11.2DS had a lower estimated total IQ and
performed worse than their siblings on all cognitive tests (Table
3). The IQ distribution of the children with 22q11.2DS was shifted
over 30 points to the left compared with the siblings (Fig. 3). Of
the children with 22q11.2, 30.6% had mild intellectual disability
(IQ range 53–69), 30.6% had a borderline IQ score (70–79) and
38.9% had an average IQ score (81–109). Older children with
22q11.2DS had lower IQs than younger children (r=70.32,
P= 0.01) but this was not the case for siblings (r=70.09,
P= 0.61). No gender differences were found for IQ between
children with 22q11.2DS and their siblings. There were no
differences between verbal and performance IQ for children with
22q11.2DS (t=70.24, P=0.82).
We found 22% of children with 22q11.2DS had higher verbal
(510 points) than performance IQ, but equally 22% had higher
performance (510 points) than verbal IQ. Children with
22q11.2DS were also found to perform worse than their siblings
on all other neurocognitive tests (Table 3).
IQ in relation to the other cognitive measures
and patterns of associations (Goal 1)
Correlation analysis (Table 4) indicated that the CANTAB
measures and the WCST did tap into neurocognitive domains that
were independent of IQ in children with 22q11.2DS. As a
sensitivity analysis, we reran the analyses comparing cognitive
performance in children with 22q11.2DS and sibling controls,
including only children with 22q11.2DS with IQ 470 and results
remained substantially the same, suggesting the findings were not
driven by the subgroup with mild intellectual disability. The
pattern of associations between the neurocognitive tests ranged
from low to modest in strength (Table 5), indicating that these
cognitive tests do measure different cognitive abilities in both
groups of children. Although the correlations between the tests
tended to be somewhat higher for children with 22q11.2DS (range
0.15 to 0.55) compared with sibling controls (70.17 to 0.44),
formal comparison indicated the magnitude of associations
was higher in children with 22q11.2DS for only 2 out of 15
correlations: RVP test with both the RTI test and perseverative
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Fig. 2 Comorbidity in children with 22q11.2 deletion syndrome.
ADHD, attention-deficit hyperactivity disorder; ASD, autism spectrum disorder; ODD, oppositional defiant disorder.
8 –
7 –
6 –
5 –
4 –
3 –
2 –
1 –
0 –
Children with 22q11.2DS with
psychopathology
Children with 22q11.2DS
without psychopathology
Siblings without
psychopathology
Siblings with
psychopathology
Intellectual disability cut-off18
50 60 70 80 90 100 110 120 130 140
.....
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
..
..
Fig. 3 IQ distributions and psychopathology of children
with 22q11.2 deletion syndrome and their siblings.
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errors of the WCST. The RTI test showed the highest correlations
not only with the measures within the attention domain (e.g. RVP
test) but also with all the measures of executive function (e.g. SOC
test) for children with 22q11.2DS. Finally, we found larger standard
deviations for most cognitive tests indicating greater variation in
the cognitive performance of children with 22q11.2DS in relation
to their siblings, with the exception of IQ and SWM tests (Table 6).
Psychopathology and cognition (Goal 2)
Initial analyses in the total sample of children with 22q11.2DS and
their siblings showed a relationship between IQ and risk for
psychopathology (i.e. ADHD diagnosis, any anxiety disorder,
and ASD screening) (Table 7). This analysis could not be
conducted for ODD because none of the siblings met criteria
for this diagnosis. In analyses stratified by group status there
was no evidence of association between IQ and psychopathology
either in children with 22q11.2DS or their siblings. In the
mediation analyses, with IQ as the mediator, the indirect effects
via IQ (Fig. 1, Mediation model, paths A and B) were considerably
weaker than the direct effects between group status and psycho-
pathology (path C) (Table 8). Similar results were obtained when
regression and mediation analyses were conducted for the other
cognitive measures (data not presented). The only exception was
an indirect effect for the SOC task component problems solved
in minimum moves (712, 95% CI 70.25 to 70.009) and ASD.
However, given the number of tests in our exploratory analysis
(n= 21), this effect did not survive correction for multiple testing.
Discussion
Psychopathology
More than half (54%) of children with 22q11.2DS met diagnostic
criteria for one or more DSM-IV-TR psychiatric disorder. They
had higher rates of ADHD, ASD, ODD and anxiety disorders
compared with sibling controls. These rates are broadly similar
to those reported in previous studies of children with
22q11.2DS (e.g. Green et al 4) and to population studies of
children with intellectual disabilities (e.g. Emerson19), indicating
that in childhood, 22q11.2DS does not seem to be related to a
specific psychiatric phenotype,7 at least as captured by current
diagnostic systems.20 It also suggests that these disorders can share
underlying pathogenic mechanisms with intellectual disability.
Comorbidity was also substantial, providing further evidence that
the effect of the deletion is widespread across a range of neuro-
developmental syndromes. This is in keeping with previous
studies of children with 22q11.2DS (e.g. James et al21), studies
of rare CNVs and single-gene disorders which similarly tend to
be associated with increased risk of many different types of
psychopathology (e.g. Miller et al22).
The frequency of psychotic-like experiences was similar
between children with 22q11.2DS and their siblings, indicating
that at this age children with 22q11.2DS are too young to exhibit
the higher rates of psychotic experiences robustly seen in late
adolescence and adulthood. Interestingly, parent and child reports
were in agreement only for one child with 22q11.2DS and none
of the siblings for whom any psychotic experiences were only by
self-report. This could be because children are not willing to share
these symptoms with their parents or due to difficulties associated
with obtaining reliable data on psychotic experiences in children
of this age.
Cognition
Our findings demonstrate that the IQ distribution of the children
with 22q11.2DS is shifted over 30 points to the left in relation to
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their siblings. This is in agreement with previous studies in
22q11.2DS6 as well as the literature on single-gene disorders
(e.g. fragile-X syndrome23) and other neurodevelopmental
syndromes (e.g. ASD and ADHD24). Even though performance
on the neurocognitive tests was generally impaired in the entire
sample of children with 22q11.2DS, it was also variable. That is,
performance on IQ was unrelated to performance on most
cognitive tests, a finding in accordance with reports in other
neurodevelopmental disorders (e.g. ADHD25). Furthermore,
among the neurocognitive tests, performance in one domain did
not represent a good indicator of performance in another domain
(as evidenced by modest correlation coefficients). However, for
children with 22q11.2DS performance on the RVP task (an
indicator of attention) was more strongly associated with
performance on the RTI test (an indicator of processing speed)
as well as with the number of perseverative errors from the WCST
(an indicator of executive function) than for their siblings.
Generally, the five-choice RTI score (an indicator of processing
speed) showed the highest correlations (0.25–0.55) for children
with 22q11.2DS, not only with measures within the domain of
attention, but also with all measures of executive function. This
is in accordance with the existing literature that underlines the
relevance and importance of processing speed to both typical
and atypical development. For example, several studies in typically
developing children show that: processing speed mediates the
developmental course of other cognitive abilities, such as working
memory and response inhibition;26 cognitive slowing might
restrict performance in other cognitive abilities such as executive
functions;26 among neurocognitive tests, processing speed best
predicts psychotic experiences.27 Furthermore, children with
22q11.2DS had greater variation in cognitive performance in
relation to their siblings, a finding in agreement with previous
reports in 22q11.2DS.28 This variation could be due to the
deletion having widespread effects in cognitive performance but
we cannot exclude the possibility of other confounding factors,
such as more attention or behavioural problems in children with
22q11.2DS in relation to their siblings, which might have
influenced their performance in the cognitive tests. We did not
find evidence of better verbal than non-verbal abilities in line with
some29 but not all previous studies.30 Moreover, although
previous studies have shown discrepancies between verbal and
performance IQ (usually between 8 to 10 points31), the number
of children with better verbal than performance IQ (510 points)
in our study was similar to the number with better performance
than verbal IQ (510 points). Therefore our study does not
support the hypothesis that 22q11.2DS is specifically associated
with non-verbal intellectual disability.
Lack of associations between cognitive impairment
and psychopathology
There has been disagreement on whether there is a relationship
between IQ and psychopathology in 22q11.2DS with some studies
reporting relationships,30 while others do not.32 In line with our
predictions, there was no relation between psychopathology and
IQ in children with 22q11.2DS.
The availability of a sample of sibling controls in which the
same assessments were conducted as in the children with
22q11.2DS, in combination with a relatively large sample size,
allowed us to conduct the first mediation analysis for this
syndrome. The findings showed that psychopathology in
22q11.2DS is not explained by indirect effects, mediated by the
children’s intellectual impairment.
We also explored the associations with other neurocognitive
measures and our results indicated only an indirect effect of the
deletion on probable ASD diagnosis through the SOC (an
indicator of planning) test. This effect, however, was in the
opposite direction than expected and therefore, given the
exploratory nature of our analysis, we interpreted this result as
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Table 4 Associations between IQ score and the other
neurocognitive measures on the CANTAB in children
with 22q11.2 deletion syndrome
IQ
Cognitive measure rho P
MTS, total correct 0.09 0.45
RTI
5-choice movement time 0.12 0.32
5-choice reaction time 0.07 0.59
RVPA 0.20 0.10
SOC
Mean initial thinking time 70.04 0.75
Mean subsequent thinking time 0.08 0.54
Problems solved in minimum moves 0.16 0.20
SWM
Between errors 0.35 0.003
Strategy 0.35 0.003
WCST
Perseverative errors 0.25 0.04
Non-perseverative errors 70.13 0.29
Failure to maintain set 70.07 0.57
WASI, Wechsler Abbreviated Scale of Intelligence; CANTAB, Cambridge
Neuropsychological Test Automated Battery; MTS, Match to Sample Visual Search;
RTI, Reaction Time; RVPA, Rapid Visual Information Processing; SOC, Stockings of
Cambridge; SWM, Spatial Working Memory; WCST, Wisconsin Card Sorting Test.
Table 5 Associations between primary neurocognitive scores
MTS RTI RVPA SOC SWM
Cognitive
measure
Children with
22q11.2DS Siblings
Children with
22q11.2DS Siblings
Children with
22q11.2DS Siblings
Children with
22q11.2DS Siblings
Children with
22q11.2DS Siblings
MTS, total correct 1 1
RTI, 5-choice reaction time 0.28 0.07 1 1
RVPA 0.33 70.07 0.55 0.14 1 1
SOC, problems solved in
minimum moves 0.18 70.12 0.35 0.35 0.28 0.19 1 1
SWM, between errors 0.15 70.17 0.26 0.20 0.25 0.44 0.28 0.26 1 1
WCST, perseverative errors 0.16 0.02 0.25 0.09 0.27 70.18 0.21 0.41 0.16 70.01
22q11.2DS, 22q11.2 deletion syndrome; MTS, Match to Sample Visual Search; RTI, Reaction Time; RVPA, Rapid Visual Information Processing; SOC, Stockings of Cambridge; SWM,
Spatial Working Memory; WCST, Wisconsin Card Sorting Test.
Figures in italic type reflect differences in magnitude of the correlations between the two groups, at the level of P50.05 but P40.01. Figures in bold signify statistical significance.
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lack of evidence for a mediated effect of the deletion through
cognition.
Strengths and limitations
This is one of the largest studies to date to include children with
22q11.2DS with a relatively narrow age range as well as sibling
controls, and one of the few studies to obtain detailed psychiatric
as well as neurocognitive phenotyping. Moreover, this is the
first study to use mediation analysis to further examine the
relationships between IQ and psychopathology. Given that
children with 22q11.2DS may have a risk of developing schizo-
phrenia in adulthood in the order of 30%,2,3 follow-up will allow
us to identify risk and protective factors for schizophrenia and to
study potential mechanisms and markers of high risk that are
unconfounded by reverse causation and medication effects.
On the other hand, even though this study is one of the largest
to date, type II errors cannot be excluded. Also, although the age
range of the children is narrow in comparison to previous studies
in children with 22q11.2DS, we cannot exclude the possibility that
significant developmental changes during that period might have
influenced our findings.
Theoretical implications
Our findings raise a number of important issues. First, it is not yet
known how the deletion can manifest itself in such a clinically
variable manner. Various factors could contribute to this
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Table 6 Results from two-group variance-comparison test in standardised cognitive performance between children with 22q11.2
deletion syndrome (22q11.2DS) and their sibling controls
Cognitive measures Children with 22q11.2DS, s.d. Siblings, s.d. F P
WASI
IQ 13.0 15.0 1.36 0.27
Verbal IQ 14.2 13.1 0.88 0.69
Performance IQ 12.4 16.6 1.84 0.03
CANTAB
MTS, total correct 1.1 0.5 0.17 50.001
RTI 1.1 0.5 0.18 50.001
5-choice movement time
5-choice reaction time 1.1 0.4 0.11 50.001
RVPA 1.1 0.4 0.12 50.001
SOC
Mean initial thinking time (5 moves) 1.2 0.4 0.14 50.001
Mean subsequent thinking time (5 moves) 1.0 1.0 0.97 0.94
Problems solved in minimum moves 0.9 0.9 0.94 0.86
SWM
Between errors 1.0 0.9 1.47 0.17
Strategy 1.1 0.9 1.52 0.14
WCST
Perseverative errors 1.1 0.5 0.20 50.001
Non-perseverative errors 1.1 0.5 0.20 50.001
WASI, Wechsler Abbreviated Scale of Intelligence; CANTAB, Cambridge Neuropsychological Test Automated Battery; MTS, Match to Sample Visual Search; RTI, Reaction Time; RVPA,
Rapid Visual Information Processing; SOC, Stockings of Cambridge; SWM, Spatial Working Memory; WCST, Wisconsin Card Sorting Test.
Six children with 22q11.2DS and three siblings did not complete any cognitive assessment, three children with 22q11.2DS did not do the WCST, two children with 22q11.2DS were mute
and therefore did not complete the WASI; other missing scores were either due to the child’s cognitive or behavioural issues.
Table 7 The relation between IQ and psychiatric diagnoses before and after adjustment for group statusa
Children with
Homogeneity of ORs
Psychiatric diagnosis n
Non-adjusted ORs
(95% CI)
22q11.2DS, stratified
ORs (95% CI)
Siblings, stratified
ORs (95% CI)
Adjusted ORs
(95% CI) w2 P
ADHD 107 1.80 (1.12–2.90) 0.66 (0.32–1.39) 1.61 (0.24–10.96) 0.74 (0.37–1.48) 0.71 0.40
Any anxiety disorder 108 1.90 (1.08–3.35) 1.40 (0.62–3.15) 0.47 (0.07–3.23) 1.19 (0.56–2.51) 1.04 0.31
ASD screeningb 106 1.86 (1.04–3.32) 1.35 (0.58–3.12) 0.47 (0.07–3.23) 1.14 (0.53–2.46) 0.96 0.33
22q11.2DS, 22q11.2 deletion syndrome; ADHD, attention-deficit hyperactivity disorder; ASD, autism spectrum disorder.
a. IQ score has been standardised to have a mean of zero and a standard deviation of one and recoded so that high score indicates worse performance. Adjusted odds ratios (ORs)
are ORs adjusted for group status.
b. ASD scoring 515 in the Social Communication Questionnaire (suggestive of ASD diagnosis).
Table 8 Direct and indirect effects via IQ of group status (22q11.2 deletion syndrome status v. control status) on psychiatric
diagnoses
Psychiatric diagnosis Indirect effect (mediated via IQ) (95% CI) Direct effect (95% CI) Total effect (95% CI)
ADHD 70.10 (70.35 to 0.13) 0.66 (0.31 to 0.93) 0.56 (0.35 to 0.70)
Any anxiety disorder 0.07 (70.17 to 0.27) 0.38 (0.01 to 0.66) 0.44 (0.20 to 0.63)
ASD screeninga 0.05 (70.25 to 0.32) 0.39 (0.00 to 0.70) 0.44 (0.17 to 0.62)
ADHD, attention-deficit hyperactivity disorder; ASD, autism spectrum disorder.
a. ASD scoring 515 in the Social Communication Questionnaire (suggestive of ASD diagnosis).
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variability, including the combined effect of reduced genetic
dosage along with background genetic variation, in the 22q11.2
region, and elsewhere in the genome, as well as positional
effects.33 For example, it has been hypothesised that dopamine
dysregulation resulting from reduced gene dosage arising from
the deletion could lead to brain disconnectivity and in turn to
predisposition to the cognitive and psychiatric deficits for a
subgroup of individuals with 22q11.2DS.34 Moreover, it is likely
that environmental exposures also play a role.
These findings suggest that the 22q11.2 deletion has
pleiotropic effects on IQ and psychopathology.9 In other words,
the deletion has largely independent effects on IQ and risk of
psychopathology. This implies that the associations seen more
generally between impaired IQ and psychopathology might reflect
the fact that cognitive impairments index genetic risk factors for
psychiatric syndromes rather than that impaired cognition
mediates the effects of risk. Indeed, there is accumulating evidence
in support of this view from recent work on schizophrenia.35
Clinical implications
The results indicate that the prevalence of psychopathology in
children with 22q11.2 DS is high, with over half meeting
DSM-IV-TR criteria. The prevalent diagnoses, which are often
comorbid in children with 22q11.2DS, include ADHD, anxiety
disorders, ODD and high rates of autistic traits. The prevalence
of intellectual disability is also high, with 31% of children with
the deletion having mild intellectual disability. Moreover, children
with 22q11.2DS seem to exhibit a generally impaired cognitive
performance, which is more variable than in the non-deleted
population (as indicated by larger standard deviations in the
performance of children with 22q11.2DS in relation to their
siblings).
Furthermore, these findings underline the potential
implications of childhood 22q11.2DS for parents and health
services and indicate the importance of early detection and
treatment. Our finding that psychopathology is not mediated by
the children’s intellectual impairment does not support the use
of cognitive remediation for ameliorating the mechanisms
underlying psychopathology in children with 22q11.2DS.
However, our examination of general, rather than more specific
cognitive functions, might have prevented the identification of
relationships between specific cognitive deficits and psychiatric
disorders.
These findings also provide no support for the suggestion
that psychopathology in 22q11.2DS is a non-specific consequence
of intellectual impairment reflecting mechanisms that differ
from those operating in more typical cases. Rather, they are
consistent with the conclusion that the mechanisms by which
psychopathology is produced in 22q11.2DS might resemble those
operating in more typical cases, and that 22q11.2DS might serve
as a model in which mechanisms of childhood psychopathology
might be studied.
In conclusion, we set out to determine the rate and nature of
psychopathology and neurocognitive dysfunction, and the
relationship between them, in children with 22q11.2DS. We found
high rates of psychopathology and impairments across a wide
range of neurocognitive functions compared with sibling controls.
We found no evidence that the presence of psychopathology is
correlated with neurocognitive impairment and it would appear
that the former is not mediated by the latter. These findings have
important clinical and theoretical implications. Further work is
required to determine whether these findings can be extended to
older age groups with 22q11.2DS, other CNVs and other high-risk
samples.
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